Press "Enter" to skip to content

New patent for Altathera Pharms drug SOTALOL HYDROCHLORIDE

0
Copyright © DrugPatentWatch. Originally published at New patent for Altathera Pharms drug SOTALOL HYDROCHLORIDE

Annual Drug Patent Expirations for SOTALOL+HYDROCHLORIDE
Annual Drug Patent Expirations for SOTALOL+HYDROCHLORIDE

Sotalol Hydrochloride is a drug marketed by Altathera Pharms Llc, Apotex, Beximco Pharms Usa, Epic Pharma Inc, Impax Pharms, Mylan, Oxford Pharms, Sun Pharm Industries, Teva, Upsher Smith Labs, and Watson Labs and, and is included in seventeen NDAs. It is available from fifteen suppliers. There is one patent protecting this drug.

The generic ingredient in SOTALOL HYDROCHLORIDE is sotalol hydrochloride. Fifteen suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Altathera Pharms drug SOTALOL HYDROCHLORIDE
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions